' Strongest Evidence Yet ' That Diabetes Drugs Are Renoprotective ' Strongest Evidence Yet ' That Diabetes Drugs Are Renoprotective

Meta-analysis of four major trials in patients with type 2 diabetes shows significant renal benefit of SGLT2 inhibitors, even in patients with reduced kidney function.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news